Wichita-based Clinical
Community Oncology Program Joins
National Clinical Trials Network
The clinica l communit y oncolog y
program led by Ascension Via Christi
has joined the Alliance for Clinical Trials
in Oncology — part of the National Cancer
Instit ute's Nationa l Cli n ica l Tr ia ls
Network, or NCTN. It also has a new name:
Cancer Research of Kansas.
For the thousa nds of patients across
Ka nsa s pa r ticipating in leading-edge
ca ncer resea rch tria ls, the tra nsition
f rom a g ra nt-f u nded n at ion a l com-
mu n it y oncolog y resea rch prog ra m
t o a m a i n memb er of NC I 's NCT N
was sea mless.
"Through Cancer Research of Kansas,
patients continue to have close-to-home
access to quality cancer care that rivals
that being provided anywhere else in the
nation — and even greater opportunities
for cancer research trial participation
in the future," says oncologist Shaker
Dakhil, MD, of Cancer Center of Kansas,
Medical Director for Oncology Services
at Ascension Via Christi and principal
investigator for a vast number of the
cancer research trials.
But for Ascension Via Christi and its
community partners, who collectively
operate 19 participating sites through-
out Kansas, the move makes for a more
Over the past 35
years, more than
18,000 patients
have been served
by Wichita's clinical
community oncology
program team.
M D N E W S . C O M /// M D N E W S G R E AT E R K A N S A S
■
2 019 1 5
